Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 5850

BillFederalHouseIn Committee
To nullify modifications made by the Food and Drug Administration on January 3, 2023, to the risk evaluation and mitigation strategy under section 505–1 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355–1) for mifepristone, and for other purposes.
About This Bill
Committee
Latest Action · October 6, 2023
Referred to the Subcommittee on Health.
Introduced
September 29, 2023
Cosponsors (1)
0D 1R
View PDF ↗
SummaryFull TextCommentsAnnotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one
No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.